Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2023.
-
Annual account missing NBB
Fiscal year 2025 was expected before 30 January 2026 and has not been filed.
Financials
Financial year 2024
Phibro Animal Health from Wavre, company number BE0472931319, closed financial year 2024 with a result of € 719,871 after tax. For that financial year Phibro Animal Health recorded revenue of € 19.7 million and equity of € 6.1 million. Compared with financial year 2023, the result moved from € 816,477 to € 719,871. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 23, 2024.
€ 6.1 million
▲ 13% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 719,871
▼ 12% vs 2023
Profit after tax over the fiscal year.
€ 1.2 million
▲ 35% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 4.5 million.
People and assets in 2024
16
▲ 1.1 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 3 million
▲ 26% vs 2023
€ 188,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 21,269
▲ 95% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 3.4 million
▼ 20% vs 2023
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 71 days on average.
€ 454,935
▲ 14% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|
| Revenue | € 19,480,766 | € 19,108,026 | € 19,729,431 | ▲ 3% |
| Profit after taxes | € 359,909 | € 816,477 | € 719,871 | ▼ 12% |
| Equity | € 4,606,303 | € 5,422,780 | € 6,142,651 | ▲ 13% |
| Total debts | € 4,712,421 | € 4,704,893 | € 4,247,604 | ▼ 10% |
| Cash | € 942,863 | € 874,346 | € 1,179,508 | ▲ 35% |
| Retained profit | € 2,917,249 | € 3,733,726 | € 4,453,597 | ▲ 19% |
| Balance sheet total | € 9,642,724 | € 10,623,673 | € 10,508,655 | ▼ 1% |
| Employees (FTE) | 10.9 | 14.9 | 16 | ▲ 1.1 |
Key figures of Phibro Animal Health, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 January 2026.
What happened to Phibro Animal Health?
What happened at Phibro Animal Health in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- JACK BENDHEIM stepped down as director. NBB
- LARRY MILLER stepped down as director. NBB
- DANIEL BENDHEIM stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 719,871 (▼ 12% vs 2023). Source: NBB ↗
- JACK BENDHEIM became a director. NBB
- DANIEL BENDHEIM became a director. NBB
- LARRY MILLER became a director. NBB
- New establishment in Wavre. KBO
In short
From € 359,909 profit in 2022 to € 719,871 profit in 2024.
Paid € 7,829 in corporate taxes since 2022.
Best year ever: 2023, with € 816,477 profit.
Pays suppliers within 71 days on average.
A new publication or filing at Phibro Animal Health? We notify you, reason included.
Follow Phibro Animal HealthDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
JACK BENDHEIM
Director
since 2021 · until 2027
LARRY MILLER
Director
since 2021 · until 2027
DANIEL BENDHEIM
Director
since 2021 · until 2027
Establishments
Establishment units
Physical locations of this company
Chemin du Stocquoy 3
1300 Wavre
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0472.931.319
- VAT number
- BE 0472.931.319
- Registered office
- Chemin du Stocquoy 3, 1300 Wavre
- Names & denominations
- Phibro Animal Health
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 October 2000
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Vervaardiging van geneesmiddelen
Vervaardiging van verdelgingsmiddelen, ontsmettingsmiddelen en andere chemische producten voor de landbouw
Vervaardiging van verdelgingsmiddelen en van andere chemische producten voor de landbouw
Groothandel in chemische producten voor industrieel gebruik
Groothandel in farmaceutische en medische artikelen
Groothandel in veevoeders
Vervaardiging van veevoeders
Groothandel in chemische producten